Cargando…
Pro-resolving and anti-arthritic properties of the MC(1) selective agonist PL8177
BACKGROUND: Melanocortins are peptides endowed with anti-inflammatory and pro-resolving activities. Many of these effects are mediated by the Melanocortin receptor 1 (MC(1)) as reported in several experimental settings. As such, MC(1) can be a viable target for the development of new therapies that...
Autores principales: | Garrido-Mesa, Jose, Thomas, Bethan Lynne, Dodd, John, Spana, Carl, Perretti, Mauro, Montero-Melendez, Trinidad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730523/ https://www.ncbi.nlm.nih.gov/pubmed/36505403 http://dx.doi.org/10.3389/fimmu.2022.1078678 |
Ejemplares similares
-
Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration
por: Dodd, John, et al.
Publicado: (2021) -
A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans
por: Dodd, John, et al.
Publicado: (2023) -
Ligand Bias and Its Association With Pro-resolving Actions of Melanocortin Drugs
por: Patruno, Sara, et al.
Publicado: (2018) -
Loss of 15-lipoxygenase disrupts T(reg) differentiation altering their pro-resolving functions
por: Marques, Raquel M., et al.
Publicado: (2021) -
Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis
por: Dalli, Jesmond, et al.
Publicado: (2014)